作者:
Goetz,C.G. [1]
;
Stebbins,G.T. [2]
;
Chung,K.A. [3]
;
Hauser,R.A. [4]
;
Miyasaki,J.M. [5]
;
Nicholas,A.P. [6]
;
Poewe,W. [7]
;
Seppi,K. [8]
;
Rascol,O. [9]
;
Stacy,M.A. [10]
;
Nutt,J.G. ;
Tanner,C.M. ;
Urkowitz,A. ;
Jaglin,J.A. ;
Ge,S.
作者单位:
Department of Neurology, Oregon Health Sciences University, Portland VA Medical Center, Portland
[1]
Parkinson's Institute and Clinical Center, Sunnyvale, CA, United States
[2]
Clinical Investigation Center CIC9302, Departments of Clinical Pharmacology and Neuroscience
[3]
Department of Neurology, University of South Florida, Tampa, FL, United States
[4]
Department of Neurology, Duke University, Durham, NC, United States
[5]
Michael J. Fox Foundation for Parkinson's Research, New York City, NY, United States
[6]
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States
[7]
The Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, ON, Canada
[8]
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
[9]
Department of Neurology, University of Alabama, Birmingham VA Medical Center, Birmingham, AL
[10]
发布时间
2013-11-20